Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Efficient Media for High Lipase Production: One Variable at a Time Approach.

Soleymani S, Alizadeh H, Mohammadian H, Rabbani E, Moazen F, MirMohammad Sadeghi H, Shariat ZS, Etemadifar Z, Rabbani M.

Avicenna J Med Biotechnol. 2017 Apr-Jun;9(2):82-86.

2.

Photoclinic.

Rabbani E, Rabbani R, Rabbani R, Abbasi S.

Arch Iran Med. 2016 Apr;19(4):295-6. doi: 0161904/AIM.0013. No abstract available.

3.

Idiopathic pulmonary fibrosis is strongly associated with productive infection by herpesvirus saimiri.

Folcik VA, Garofalo M, Coleman J, Donegan JJ, Rabbani E, Suster S, Nuovo A, Magro CM, Di Leva G, Nuovo GJ.

Mod Pathol. 2014 Jun;27(6):851-62. doi: 10.1038/modpathol.2013.198. Epub 2013 Nov 15.

4.

Mapping of noise impact provoked by the execution of foundation piles at high rise building sites.

de Araújo AG, Gusmão AD, Rabbani ER, Fucale SP.

Work. 2012;41 Suppl 1:3291-300. doi: 10.3233/WOR-2012-0596-3291.

PMID:
22317218
5.

Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.

Ilan Y, Ohana M, Pappo O, Margalit M, Lalazar G, Engelhardt D, Rabbani E, Nagler A.

Transplantation. 2007 Feb 27;83(4):458-67.

PMID:
17318079
6.

Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice.

Margalit M, Shalev Z, Pappo O, Sklair-Levy M, Alper R, Gomori M, Engelhardt D, Rabbani E, Ilan Y.

J Pharmacol Exp Ther. 2006 Oct;319(1):105-10. Epub 2006 Jun 30.

PMID:
16815870
7.

A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach.

Margalit M, Israeli E, Shibolet O, Zigmond E, Klein A, Hemed N, Donegan JJ, Rabbani E, Goldin E, Ilan Y.

Am J Gastroenterol. 2006 Mar;101(3):561-8.

PMID:
16542292
8.

Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping.

Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O, Gomori M, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

J Pathol. 2006 May;209(1):121-8.

PMID:
16482497
9.

Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation.

Elinav E, Abd-Elnabi A, Pappo O, Bernstein I, Klein A, Engelhardt D, Rabbani E, Ilan Y.

J Hepatol. 2006 Mar;44(3):529-36. Epub 2005 Sep 19.

PMID:
16310278
10.

Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.

Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O, Gomori M, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

J Pathol. 2006 Jan;208(1):74-81.

PMID:
16261527
11.

Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes.

Margalit M, Abu Gazala S, Alper R, Elinav E, Klein A, Doviner V, Sherman Y, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Am J Physiol Gastrointest Liver Physiol. 2005 Nov;289(5):G917-25. Epub 2005 Jun 23. Erratum in: Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G927. Ghazala, Samir Abu [corrected to Abu Gazala, Samir].

12.

Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial.

Israeli E, Goldin E, Shibolet O, Klein A, Hemed N, Engelhardt D, Rabbani E, Ilan Y.

World J Gastroenterol. 2005 May 28;11(20):3105-11.

13.

Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.

Ilan Y, Margalit M, Ohana M, Gotsman I, Rabbani E, Engelhardt D, Nagler A.

Hum Immunol. 2005 Mar;66(3):231-40.

PMID:
15784461
14.

Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.

Margalit M, Shibolet O, Klein A, Elinav E, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Int J Cancer. 2005 Jun 20;115(3):443-9.

15.

Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.

Margalit M, Ilan Y, Ohana M, Safadi R, Alper R, Sherman Y, Doviner V, Rabbani E, Engelhardt D, Nagler A.

Bone Marrow Transplant. 2005 Jan;35(2):191-7.

PMID:
15558045
16.

Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.

Israeli E, Safadi R, Melhem A, Pappo O, Shibolet O, Klein A, Hemed N, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Liver Int. 2004 Aug;24(4):295-307.

PMID:
15287852
17.

Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.

Shibolet O, Alper R, Zlotogarov L, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Oncology. 2004;66(4):323-30.

PMID:
15218301
18.

The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.

Shibolet O, Alper R, Zolotarov L, Trop S, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Clin Immunol. 2004 Apr;111(1):82-92.

PMID:
15093555
19.

Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.

Safadi R, Israeli E, Papo O, Shibolet O, Melhem A, Bloch A, Rowe M, Alper R, Klein A, Hemed N, Segol O, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Am J Gastroenterol. 2003 Nov;98(11):2505-15.

PMID:
14638356
20.

Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis.

Shibolet O, Kalish Y, Klein A, Alper R, Zolotarov L, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

J Leukoc Biol. 2004 Jan;75(1):76-86. Epub 2003 Oct 13.

PMID:
14557387
21.

Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.

Nagler A, Ohana M, Alper R, Doviner V, Sherman Y, Rabbani E, Engelhardt D, Ilan Y.

Bone Marrow Transplant. 2003 Aug;32(4):363-9.

PMID:
12900772
22.

Early expression of interferon gamma following oral antigen administration is associated with peripheral tolerance induction.

Kolker O, Klein A, Alper R, Menachem Y, Shibolet O, Rabbani E, Engelhardt D, Ilan Y.

Microbes Infect. 2003 Jul;5(9):807-13.

PMID:
12850207
23.

NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.

Shibolet O, Alper R, Zlotogarov L, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Int J Cancer. 2003 Aug 20;106(2):236-43.

24.

Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.

Gotsman I, Alper R, Klein A, Rabbani E, Engelhardt D, Ilan Y.

Cancer. 2002 Jan 15;94(2):406-14.

25.

Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice.

Gotsman I, Israeli D, Alper R, Rabbani E, Engelhardt D, Ilan Y.

Int J Cancer. 2002 Jan 1;97(1):52-7.

26.

Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect.

Shlomai A, Trop S, Gotsman I, Jurim O, Diment J, Alper R, Rabbani E, Engelhardt D, Ilan Y.

J Pathol. 2001 Nov;195(4):498-507.

PMID:
11745683
27.

Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.

Gotsman I, Shlomai A, Alper R, Rabbani E, Engelhardt D, Ilan Y.

J Pharmacol Exp Ther. 2001 Jun;297(3):926-32.

PMID:
11356912
28.

Induction of oral tolerance towards hepatitis B envelope antigens in a murine model.

Gotsman I, Beinart R, Alper R, Rabbani E, Engelhardt D, Ilan Y.

Antiviral Res. 2000 Oct;48(1):17-26.

PMID:
11080537
29.

Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model.

Ilan Y, Gotsman I, Pines M, Beinart R, Zeira M, Ohana M, Rabbani E, Engelhardt D, Nagler A.

Blood. 2000 Jun 1;95(11):3613-9.

PMID:
10828052
30.

Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes.

Ilan Y, Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rabbani E, Engelhardt D, Chowdhury NR, Chowdhury JR, Goldin E.

Am J Gastroenterol. 2000 Apr;95(4):966-73.

PMID:
10763946
31.

Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.

Nagler A, Pines M, Abadi U, Pappo O, Zeira M, Rabbani E, Engelhardt D, Ohana M, Chowdhury NR, Chowdhury JR, Ilan Y.

Hepatology. 2000 Mar;31(3):641-8.

PMID:
10706554
32.

A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice.

Brown JJ, Parashar B, Moshage H, Tanaka KE, Engelhardt D, Rabbani E, Roy-Chowdhury N, Roy-Chowdhury J.

Hepatology. 2000 Jan;31(1):173-81.

PMID:
10613743
33.

Presence of polyriboadenylate sequences in pulse-labeled RNA of Escherichia coli.

Srinivasan PR, Ramanarayanan M, Rabbani E.

Proc Natl Acad Sci U S A. 1975 Aug;72(8):2910-4.

34.

Role of the translocation factor G in the regulation of ribonucleic acid synthesis.

Rabbani E, Srinivasan PR.

J Bacteriol. 1973 Mar;113(3):1177-83.

Supplemental Content

Loading ...
Support Center